The Europe biosimilar market was valued at USD 10.13 Billion in 2024, driven by rising adoption in chronic disease treatment. It is expected to grow at a CAGR of 12.80% during 2025-2034, reaching nearly USD 33.78 Billion by 2034, supported by patent expirations and increasing healthcare demand. https://www.expertmarketresearch.com/reports/europe-biosimilar-market